Sabra Healthcare REIT (NASDAQ:SBRA) Getting Somewhat Positive Press Coverage, Accern Reports
News coverage about Sabra Healthcare REIT (NASDAQ:SBRA) has trended somewhat positive recently, according to Accern Sentiment. The research group identifies negative and positive news coverage by reviewing more than twenty million blog and news sources. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. Sabra Healthcare REIT earned a news impact score of 0.19 on Accern’s scale. Accern also assigned media coverage about the real estate investment trust an impact score of 47.555534487574 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the near term.
These are some of the news articles that may have effected Accern’s analysis:
- Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) Rating Lowered to Sell at BidaskClub (techkenyot.com)
- Sabra Health Care REIT Set to Join S&P MidCap 400; Barracuda Networks to Join S&P SmallCap 600 (finance.yahoo.com)
- Ex-Div Reminder for Sabra Health Care REIT Series A Cumulative Redeemable Preferred Stock (nasdaq.com)
- See what the IHS Markit Score report has to say about Sabra Health Care REIT Inc. (finance.yahoo.com)
- Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) to Issue Dividend of $0.36 (americanbankingnews.com)
Sabra Healthcare REIT (NASDAQ SBRA) traded down 2.14% during mid-day trading on Friday, hitting $21.45. The company had a trading volume of 2,988,847 shares. Sabra Healthcare REIT has a 12-month low of $19.30 and a 12-month high of $29.10.
The company also recently disclosed a dividend, which will be paid on Friday, August 18th. Shareholders of record on Wednesday, August 16th will be paid a $0.3599 dividend. The ex-dividend date is Monday, August 14th. Sabra Healthcare REIT’s dividend payout ratio (DPR) is 145.76%.
A number of analysts recently issued reports on SBRA shares. Zacks Investment Research downgraded Sabra Healthcare REIT from a “hold” rating to a “sell” rating in a research report on Thursday, June 8th. Cantor Fitzgerald reaffirmed a “buy” rating and issued a $30.00 target price on shares of Sabra Healthcare REIT in a research report on Monday, May 8th. BidaskClub downgraded Sabra Healthcare REIT from a “hold” rating to a “sell” rating in a research report on Thursday, July 13th. Jefferies Group LLC reaffirmed a “hold” rating and issued a $28.00 target price on shares of Sabra Healthcare REIT in a research report on Friday, May 12th. Finally, Mizuho reaffirmed a “neutral” rating on shares of Sabra Healthcare REIT in a research report on Wednesday, June 28th. One investment analyst has rated the stock with a sell rating, eight have given a hold rating and one has assigned a buy rating to the company’s stock. The company has a consensus rating of “Hold” and an average price target of $26.57.
WARNING: This report was posted by Daily Political and is the property of of Daily Political. If you are viewing this report on another website, it was stolen and republished in violation of international copyright and trademark legislation. The correct version of this report can be accessed at https://www.dailypolitical.com/2017/08/12/sabra-healthcare-reit-nasdaqsbra-getting-somewhat-positive-press-coverage-accern-reports.html.
About Sabra Healthcare REIT
Sabra Health Care REIT, Inc is a real estate investment trust. The Company, through its subsidiaries, owns and invests in real estate serving the healthcare industry. The Company’s segment includes investments in healthcare-related real estate properties. The Company’s primary business consists of acquiring, financing and owning real estate property to be leased to third-party tenants in the healthcare sector.
Receive News & Ratings for Sabra Healthcare REIT Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sabra Healthcare REIT Inc. and related companies with MarketBeat.com's FREE daily email newsletter.